More on VTRS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-1.6% Growth)
- Ratings (3.8 Score)
- Holders
- Dividends (3.1% Yield)

Upcoming Events

- Earnings (8/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Viatris Inc (NQ:VTRS)
Delayed: 15.56 -0.13 (0.83%)
Prev. Close $15.69  
Open$15.68 
52 Wk High$ 
52 Wk Low$ 
Day High$15.72 
Day Low$15.50 
P/E N/A  
EPS$ 
Volume6,970,706 

Friends, Peers and Foes (?): TEVA, LXRX, AMRX SLGL (more...)

May 27, 2026 02:49 PM Viatris Inc (VTRS) 4200 contracts of July 15 puts trade
May 19, 2026 03:58 AM Viatris (VTRS) PT Raised to $22 at Barclays
May 18, 2026 08:02 AM FDA accepts Viatris drug application for fast-acting meloxicam pain treatment
May 18, 2026 08:01 AM U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
May 15, 2026 04:34 PM Form 8-K Viatris Inc For: May 15
May 7, 2026 05:04 PM Viatris (VTRS) PT Raised to $20 at Truist Securities
May 7, 2026 04:30 PM Viatris to Present at the Bank of America Securities 2026 Healthcare Conference
May 7, 2026 04:04 PM Form 10-Q Viatris Inc For: Mar 31
May 7, 2026 07:48 AM Form 8-K Viatris Inc For: May 07
May 7, 2026 07:01 AM Viatris Inc (VTRS) Tops Q1 EPS by 8c, provides guidance
View All Articles

Entities mentioned with VTRS

View All Entities